solanezumab (100)(62)

Structure	 

Heavy chain / Chaone lourde / Cadena pesada

EVQLVESGGG LVQPGGSLRL SCAASGFTFS RYSMSWVRQA PGKGLELVAQ  50

INSVGNSTYY PDTVKGRFTI SRDNAKNTLY LQMNSLRAED TAVYYCASGD 100

YWGQGTLVTV SSASTKGPSV FPLAPSSKST SGGTAALGCL VKDYFPEPVT 150

VSWNSGALTS GVHTFPAVLQ SSGLYSLSSV VTVPSSSLGT QTYICNVNHK 200

PSNTKVDKKV EPKSCDKTHT CPPCPAPELL GGPSVFLFPP KPKDTLMISR 250

TPEVTCVVVD VSHEDPEVKF NWYVDGVEVH NAKTKPREEQ YNSTYRVVSV 300

LTVLHQDWLN GKEYKCKVSN KALPAPIEKT ISKAKGQPRE PQVYTLPPSR 350

DELTKNQVSL TCLVKGFYPS DIAVEWESNG QPENNYKTTP PVLDSDGSFF 400

LYSKLTVDKS RWQQGNVFSC SVMHEALHNH YTQKSLSLSP G          441

Light chain / Chaone lygire / Cadena ligera

DVVMTQSPLS LPVTLGQPAS ISCRSSQSLI YSDGNAYLHW FLQKPGQSPR  50

LLIYKVSNRF SGVPDRFSGS GSGTDFTLKI SRVEAEDVGV YYCSQSTHVP 100

WTFGQGTKVE IKRTVAAPSV FIFPPSDEQL KSGTASVVCL LNNFYPREAK 150

VQWKVDNALQ SGNSQESVTE QDSKDSTYSL SSTLTLSKAD YEKHKVYACE 200

VTHQGLSSPV TKSFNRGEC                                   219

Disulfide bridges location / Position des ponts disulfure / Posiciones
de los puentes disulfuro

Intra-H	22-96	139-195	256-316	362-420

	22??-96??	139??-195??	256??-316??	362??-420??

Intra-L	23?-93?	139?-199?



	23???-93???	139???-199???



Inter-H-L	215-219?	215??-219???



Inter-H-H	221-221??	224-224??





N-glycosylation sites / Sites de N-glycosylation / Posiciones de
N-glicosilaciun

292, 292??

Molecular formula	C6396H9922N1712O1996S42

Description

immunoglobulin G1-kappa, anti-[Homo sapiens amyloid-beta (Abeta) peptide
soluble monomer], humanized monoclonal antibody;

gamma1 heavy chain [humanized VH (Homo sapiens IGHV3-23*04 (87.60%)
-(IGHD)-IGHJ4*01) [8.8.5] (1-112) -Homo sapiens IGHG1*01, CH3 K130>del
(113-441)], (215-219?)-disulfide with kappa light chain (1'-219')
[humanized V-KAPPA (Homo sapiens IGKV2-30*01 (90.00%) -IGKJ1*01)
[11.3.9] (1?-112?) -Homo sapiens IGKC*01 (113?-219?)];
(221-221":224-224")-bisdisulfide dimer 

	

WHO 

International Nonproprietary Names Programme	

9097

December 2008

Page 1/1

		

